NYSE:ZTSPharmaceuticals
Zoetis (ZTS) Valuation Check After $1.75 Billion Convertible Issue and 2026 Dividend Hike
Zoetis (ZTS) just gave investors a lot to chew on, completing a $1.75 billion convertible bond issue while also lifting its quarterly dividend by 6% for early 2026.
See our latest analysis for Zoetis.
Those financing moves come after a choppy stretch for the stock, with a 1 day share price return of 1.26% but a 1 year total shareholder return of minus 23.65%. This suggests longer term momentum has been fading even as management signals confidence.
If you are rethinking your healthcare...